All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
03/29/01	10-K	Annual report pursuant to Section 13 and 15(d) Related Documents EX-3.5 EX-10.225 EX-10.226 EX-10.227 EX-10.228 EX-10.229 EX-10.230 EX-21.1 EX-23.1 EX-23.2			165
03/07/01	15-12G	Notice of termination of registration of a class of securities under Section 12(g)			1
02/12/01	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
01/19/01	S-3	Registration statement for specified transactions by certain issuers Related Documents EX-5.1 EX-23.1			23
01/08/01	8-K	Current report filing Related Documents EX-99.1			3
01/04/01	8-K	Current report filing Related Documents EX-99.1			4
11/14/00	10-Q	Quarterly report pursuant to Section 13 or 15(d) Related Documents EX-27.1			19
11/06/00	8-K	Current report filing Related Documents EX-1			3
10/10/00	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			2
09/11/00	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-4			10